- Filed
- Feb 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 5, 2025 | 3.99M sh |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $519.71K |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $2.07M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2023 | $3.66M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $888.74K |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $798.47K |
| Current Assets | Q2 2025 · Dec 31, 2024 | $1.45M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $2.43M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $2.6M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $2.14M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $3.17M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $3.31M |
| Capex | Q2 2025 · Dec 31, 2023 | $1.17K |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | −$1.58M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $4.38M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $5.25M |
| Stockholders Equity | Q2 2025 · Jun 30, 2023 | $6.08M |
| Eps Diluted restated | Q2 2025 · Dec 31, 2023 | −$0.36 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.71 |
| Eps Basic restated | Q2 2025 · Dec 31, 2023 | −$0.36 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.71 |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $443.8K |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $882.06K |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $331.22K |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $664.66K |
| Net Income | Q2 2025 · Dec 31, 2023 | −$905.61K |
| Net Income | Q2 2025 · Dec 31, 2023 | −$1.8M |
| Net Income | Q2 2025 · Sep 30, 2023 | −$890.69K |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$956.08K |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$1.91M |
| Revenue | Q2 2025 · Dec 31, 2023 | $41.44K |
| Revenue | Q2 2025 · Dec 31, 2023 | $104.78K |